 Connection
Sarah Rowan to Humans
This is a "connection" page, showing publications Sarah Rowan has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.329 |
|
|
|
-
Rowan SE, Wyles DL. Don't Put Off Until Tomorrow What You Can Do Today: Hospital Admissions as an Opportunity to Treat Hepatitis C. Clin Infect Dis. 2024 03 20; 78(3):591-593.
Score: 0.025
-
Rigolon A, N?meth J, Anderson-Gregson B, Miller AR, deSouza P, Montague B, Hussain C, Erlandson KM, Rowan SE. The neighborhood built environment and COVID-19 hospitalizations. PLoS One. 2023; 18(6):e0286119.
Score: 0.024
-
Rowan SE, Haukoos J, Kamis KF, Hopkins E, Gravitz S, Lyle C, Al-Tayyib AA, Gardner EM, Galbraith JW, Hsieh YH, Lyons MS, Rothman RE, White DAE, Morgan JR, Linas BP, Sabel AL, Wyles DL. The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis C. Trials. 2023 Jan 27; 24(1):63.
Score: 0.024
-
Haukoos J, Faryar K, Rowan S. Human Immunodeficiency Virus Pre-Exposure Prophylaxis: The Next Wave in Emergency Department-Based Human Immunodeficiency Virus Prevention. Ann Emerg Med. 2023 04; 81(4):482-484.
Score: 0.023
-
Rowan SE, McCormick DW, Wendel KA, Scott T, Chavez-van de Hey J, Wilcox K, Stella SA, Kamis K, Burman WJ, Marx GE. Lower Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among People Experiencing Homelessness Tested in Outdoor Encampments Compared With Overnight Shelters: Denver, Colorado, June-July 2020. Clin Infect Dis. 2022 08 24; 75(1):e157-e164.
Score: 0.023
-
Rowan SE, Patel RR, Schneider JA, Smith DK. Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention. Lancet HIV. 2021 02; 8(2):e114-e120.
Score: 0.020
-
Rowan SE, Kamis KF, Beum R, Bryan K, Gawenus L, Colon Sanchez D, Hurley H. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program. J Infect Dis. 2020 09 02; 222(Suppl 5):S384-S391.
Score: 0.020
-
Rowan SE, Muething L, Spielmann K, Blum J, Lou Y, Vaughn S, Burman WJ. The Yield of Birth Cohort Screening for Hepatitis C in Community Health Centers. J Gen Intern Med. 2019 10; 34(10):2003-2004.
Score: 0.019
-
Rowan SE, Rogers M, Bayer J, Smith L, Gardner EM, Johnson S, Langness J. Treatment of Hepatitis C Virus in HIV-Coinfected Individuals in Real-world Clinical Settings: Results From 2 Large HIV Care Clinics. Clin Infect Dis. 2016 10 01; 63(7):994-5.
Score: 0.015
-
Haukoos JS, Rowan SE. Screening for HIV infection. BMJ. 2016 Jan 19; 532:i1.
Score: 0.014
-
Rowan SE, Burman WJ, Johnson SC, Connick E, Reirden D, Daniloff E, Gardner EM. Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city. AIDS Patient Care STDS. 2014 Sep; 28(9):475-82.
Score: 0.013
-
Rowan SE, Levi ME, Youngwerth JM, Brauer B, Everson GT, Johnson SC. The variable presentations and broadening geographic distribution of hepatic fascioliasis. Clin Gastroenterol Hepatol. 2012 Jun; 10(6):598-602.
Score: 0.011
-
Bredenberg E, Callister C, Dafoe A, Holliman BD, Rowan SE, Calcaterra SL. Subspecialty physicians' perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study. Harm Reduct J. 2024 07 25; 21(1):140.
Score: 0.007
-
Haukoos J, Hopkins E, Campbell JD, Lyons MS, Rothman RE, Hsieh YH, White DAE, Trent S, Al-Tayyib AA, Gardner EM, Sabel AL, Rowan SE. Cost-Effectiveness of HIV Screening in Emergency Departments: Results From the Pragmatic Randomized HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial. Ann Emerg Med. 2024 Sep; 84(3):234-243.
Score: 0.006
-
Lovett A, Luder R, Lillis RA, Butler I, Siren J, Gomez S, Kamis K, Obafemi O, Rowan SE, Baral S, Clement ME. Client Perspectives on the Development of a Rapid PrEP Initiative at a Sexual Health Center in New Orleans, Louisiana. J Int Assoc Provid AIDS Care. 2024 Jan-Dec; 23:23259582241258559.
Score: 0.006
-
Obafemi OA, Rowan SE, Nishiyama M, Wendel KA. Mycoplasma genitalium: Key Information for the Primary Care Clinician. Med Clin North Am. 2024 Mar; 108(2):297-310.
Score: 0.006
-
Shepard Z, Vargas Barahona L, Montalbano G, Rowan SE, Franco-Paredes C, Madinger N. Bartonella quintana Infection in People Experiencing Homelessness in the Denver Metropolitan Area. J Infect Dis. 2022 10 07; 226(Suppl 3):S315-S321.
Score: 0.006
-
Brooks KM, Castillo-Mancilla JR, Morrow M, Mawhinney S, Rowan SE, Wyles D, Blum J, Huntley R, Salah L, Tehrani A, Jimmerson LC, Roon L, Bushman LR, Anderson PL, Kiser JJ. Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol use. J Antimicrob Chemother. 2022 04 27; 77(5):1396-1403.
Score: 0.006
-
Haukoos JS, Rowan SE, Galbraith JW, Rothman RE, Hsieh YH, Hopkins E, Houk RA, Toerper MF, Kamis KF, Morgan JR, Linas BP, Al-Tayyib AA, Gardner EM, Lyons MS, Sabel AL, White DAE, Wyles DL. The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departments. Trials. 2022 Apr 25; 23(1):354.
Score: 0.006
-
Scott E, Rowan S, Chandler K, Fisher A, Hill B, Hill J, Marx GE, Farrell E, Wendel K, Stella SA. Lessons Learned through Implementing SARS-CoV-2 Testing and Isolation for People Experiencing Homelessness in Congregate Shelters. Prog Community Health Partnersh. 2022; 16(2S):13-22.
Score: 0.005
-
Kamis KF, Barbera L, Abdo M, Rowan SE, Hussain C, Gardner EM, Johnson SC, MaWhinney S, Davis AJ, Carlson J, Kozacka KA, Erlandson KM. Risk Factors for Hospitalization in People With HIV and COVID-19. J Acquir Immune Defic Syndr. 2021 11 01; 88(3):e22.
Score: 0.005
-
Haukoos JS, White DAE, Rowan SE, Lyle C, Gravitz S, Basham K, Godoy A, Kamis K, Hopkins E, Anderson E. Development of a 2-step algorithm to identify emergency department patients for HIV pre-exposure prophylaxis. Am J Emerg Med. 2022 01; 51:6-12.
Score: 0.005
-
Barbera LK, Kamis KF, Rowan SE, Davis AJ, Shehata S, Carlson JJ, Johnson SC, Erlandson KM. HIV and COVID-19: review of clinical course and outcomes. HIV Res Clin Pract. 2021 08; 22(4):102-118.
Score: 0.005
-
Marx GE, Biggerstaff BJ, Nawrocki CC, Totten SE, Travanty EA, Burakoff AW, Scott T, De Hey JC, Carlson JJ, Wendel KA, Harcourt JL, Tamin A, Thomas JD, Rowan SE. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 on Self-Collected Saliva or Anterior Nasal Specimens Compared With Healthcare Personnel-Collected Nasopharyngeal Specimens. Clin Infect Dis. 2021 07 15; 73(Suppl 1):S65-S73.
Score: 0.005
-
Haukoos JS, Lyons MS, Rothman RE, White DAE, Hopkins E, Bucossi M, Ruffner AH, Ancona RM, Hsieh YH, Peterson SC, Signer D, Toerper MF, Saheed M, Pfeil SK, Todorovic T, Al-Tayyib AA, Bradley-Springer L, Campbell JD, Gardner EM, Rowan SE, Sabel AL, Thrun MW. Comparison of HIV Screening Strategies in the Emergency Department: A Randomized Clinical Trial. JAMA Netw Open. 2021 07 01; 4(7):e2117763.
Score: 0.005
-
Haukoos JS, White DAE, Rowan SE, Lyle C, Gravitz S, Basham K, Godoy A, Kamis K, Hopkins E, Anderson E. HIV Risk and Pre-Exposure Prophylaxis Eligibility Among Emergency Department Patients. AIDS Patient Care STDS. 2021 06; 35(6):211-219.
Score: 0.005
-
Brooks KM, Castillo-Mancilla JR, Morrow M, MaWhinney S, Blum J, Wyles DL, Rowan SE, Ibrahim ME, Zheng JH, Johnson B, Gomez J, Choi YJ, Cendali F, Haas H, Roon L, Bushman LR, Anderson PL, Kiser JJ. Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir. J Antimicrob Chemother. 2020 11 01; 75(11):3303-3310.
Score: 0.005
-
Obafemi OA, Wendel KA, Anderson TS, Scott TE, Rowan SE, Travanty EA, Rietmeijer CA. Rapid Syphilis Testing for Men Who Have Sex With Men in Outreach Settings: Evaluation of Test Performance and Impact on Time to Treatment. Sex Transm Dis. 2019 03; 46(3):191-195.
Score: 0.004
-
Hawkins KL, Montague BT, Rowan SE, Beum R, McLees MP, Johnson S, Gardner EM. Boosted darunavir and dolutegravir dual therapy among a cohort of highly treatment-experienced individuals. Antivir Ther. 2019; 24(7):513-519.
Score: 0.004
-
Bhatia R, Modali L, Lowther M, Glick N, Bell M, Rowan S, Keglovitz K, Schneider J. Outcomes of Preexposure Prophylaxis Referrals From Public STI Clinics and Implications for the Preexposure Prophylaxis Continuum. Sex Transm Dis. 2018 01; 45(1):50-55.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|